Applications of cyclic peptide nanotubes (cPNTs)
Authors:
Open Access
- 1 January 2019
- journal article
- review article
- Published by The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA) in Journal of Food and Drug Analysis
- Vol. 27 (1) , 32-47
Abstract
Self-assembled cyclic peptide nanotubes (cPNTs) have recently drawn particular attention as one of the most intriguing nanostructures in the field of nanotechnology. Given their unique features including high surface area, increased drug loading, environmental stability, enhanced permeation, and modifiable drug release, these hollow tubular structures can be constructed with cyclic di-, tri-, tetra-, hexa-, octa-, and decapeptides with various amino acid sequences, enantiomers, and functionalized side chains and can be applied for antiviral and antibacterial drugs, drug delivery and gene delivery vectors, organic electronic devices, and ionic or molecular channels. Recent publications have presented promising results regarding the use of cPNTs as drugs or biomedical devices. However, there is an urgent need for the further in vivo nanotoxicity and safety testing of these nanotubes to evaluate their suitability in different fields.Keywords
Funding Information
- Ministry of Science and Technology (107-2320-B-038 -045, 107-2321-B-006 -016)
This publication has 82 references indexed in Scilit:
- Magnetic Silica Nanotubes: Synthesis, Drug Release, and Feasibility for Magnetic HyperthermiaACS Applied Materials & Interfaces, 2012
- Self-Assembling Peptide Nanotubes with Antiviral Activity against Hepatitis C VirusChemistry & Biology, 2011
- Molecular Insights on the Cyclic Peptide Nanotube-Mediated Transportation of Antitumor Drug 5-FluorouracilMolecular Pharmaceutics, 2010
- Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriersExpert Opinion on Drug Delivery, 2010
- Antibacterial cyclic d,l-α-glycopeptidesChemical Communications, 2009
- Designer self-assembling peptide nanomaterialsNano Today, 2009
- The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticlesParticle and Fibre Toxicology, 2009
- Polymeric carriers: role of geometry in drug deliveryExpert Opinion on Drug Delivery, 2008
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences, 2008
- Shape effects of filaments versus spherical particles in flow and drug deliveryNature Nanotechnology, 2007